The benefits of using peritoneal dialysis over hemodialysis is expected to attract patients with chronic renal diseases and fuel the innovations and market growth of peritoneal dialysis.
The key market players analyzed in the study are Fresenius Medical Care AG & Co. KGaA, DaVita Inc., Baxter International, Inc., B. Braun Avitum AG, Nipro Corporation, Nikkiso Co. Ltd., Diaverum Deutschland GmbH., Asahi Kasei Corporation, NxStage Medical, Inc., and Medicators, Inc. These players have implemented various strategies such as partnerships, mergers & acquisitions, expansions, collaborations, joint ventures, and others to gain a stronghold in the market.
Allied Market Research recently published a report, titled, “Dialysis Market by Type [Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, and Nocturnal Hemodialysis) and Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis)], Products & Services [Equipment (Dialysis Machines, Water Treatment Systems, and Others), Consumables (Dialyzers, Catheters, and Others), Drugs, and Services], and End User (In-center Dialysis and Home Dialysis) – Global Opportunity Analysis and Industry Forecast, 2017-2023.” The report provides comprehensive analyses of the top winning strategies, industry dynamics, market size & estimations, key market segments, and competitive landscape. According to the report, the global dialysis market is expected to reach $118.51 billion by 2023 from $91 billion in 2017, registering a CAGR of 4.4% from 2018 to 2023.
Increase in government funding for dialysis, rise in incidence of hypertension & diabetes, surge in the number of ESRD patients, and dearth of kidney donors drive the growth of the market. However, product recalls and health risks & complications associated with dialysis hamper the growth of the market. On the other hand, technological advancements and growing inclination toward home peritoneal dialysis treatment would create new pathways to the market players in future.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/374
Hemodialysis segment to remain dominant throughout 2023
Hemodialysis segment contributed nearly nine-tenths share of the total market revenue in 2017 and is expected to remain dominant throughout the forecast period. This is attributed to technological advancements in the medical sector, proliferation of dialysis centers, and increase in prevalence of chronic conditions among the geriatric population. However, the peritoneal dialysis segment would grow at the fastest CAGR of 6.1% from 2018 to 2023, owing to simplicity of the procedure, reduced need for trained medical staff, and minimal requirement for technical support & electricity.
Services segment to maintain dominance through 2023
Services segment contributed more than two-thirds of the total market revenue in 2017 and is expected to retain its lead through 2023. This is due to rise in the number of treatment centers and improvement in home-based services. The consumables segment is expected to register the highest CAGR of 5.9% from 2018 to 2023, owing to increase in usage of all dialysis procedures as consumables are disposable in nature due to high risk of contamination.
In-center dialysis segment to retain lion’s share through 2023
In-center dialysis segment accounted for nearly 85% of the total market revenue in 2017 and is projected to maintain its lead through 2023. This is due to the presence of a large number of dialysis centers and availability of skilled workforce & advanced equipment at these centers. However, the home dialysis segment is expected to register the highest CAGR of 7.0% from 2018 to 2023, owing to the ease & convenience offered by these services, high preference among patients, and advancements in technologies related to home dialysis equipment.
North America to maintain its dominance by 2023
North America accounted for nearly three-fifths of the total market revenue in 2017 and is expected to maintain its lead throughout 2023, owing to the high prevalence of hypertension & diabetes, increase in disposable income, and high adoption rate of technologically advanced products in the region. However, Asia-Pacific would witness the highest CAGR of 7.9% from 2018 to 2023, owing to surge in incidence of kidney disorders, increase in healthcare expenditure, and low rate of organ transplantation.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
